Co-Authors
This is a "connection" page, showing publications co-authored by Andrea Minervini and Marco Falcone.
Connection Strength
0.290
-
Extracorporeal Shock Wave Therapy in Peyronie's Disease: Clinical Efficacy and Safety from a Single-Arm Observational Study. World J Mens Health. 2019 Sep; 37(3):339-346.
Score: 0.051
-
Sildenafil 25 mg ODT + Collagenase Clostridium hystoliticum vs Collagenase Clostridium hystoliticum Alone for the Management of Peyronie's Disease: A Matched-Pair Comparison Analysis. J Sex Med. 2018 10; 15(10):1472-1477.
Score: 0.049
-
Predictors of treatment success after collagenase Clostridium histolyticum injection for Peyronie's disease: development of a nomogram from a multicentre single-arm, non-placebo controlled clinical study. BJU Int. 2018 10; 122(4):680-687.
Score: 0.048
-
Predictive Factors of Patients' and Their Partners' Sexual Function Improvement After Collagenase Clostridium Histolyticum Injection for Peyronie's Disease: Results From a Multi-Center Single-Arm Study. J Sex Med. 2018 05; 15(5):716-721.
Score: 0.048
-
Effectiveness of highly purified urofollitropin treatment in patients with idiopathic azoospermia before testicular sperm extraction. Urologia. 2018 Feb; 85(1):19-21.
Score: 0.047
-
Effectiveness and Safety of Oro-Dispersible Sildenafil in a New Film Formulation for the Treatment of Erectile Dysfunction: Comparison Between Sildenafil 100-mg Film-Coated Tablet and 75-mg Oro-Dispersible Film. J Sex Med. 2017 12; 14(12):1606-1611.
Score: 0.046